Tang IVF Clinic
TANG IVF CLINICTANG IVF CLINICBishkek, Kyrgyzstan
Appointments & enquiries+996 755 666 688Monday–Saturday, 09:00–17:00
Home /

Testing for a known inherited condition

Discuss embryo testing when a specific inherited single-gene condition has been identified in the family.

Understanding pgt-m & genetic counselling

PGT-M is a condition-specific test used with IVF to investigate a known single-gene disorder. It is different from PGT-A, which screens chromosome number. A genetic consultation and review of the familial diagnosis are needed before a laboratory can determine whether a testing strategy can be prepared.

Who may discuss this option?

PGT-M may be considered when a specific inherited single-gene condition has been identified and a testing strategy may be feasible.

Before your consultation

  • The original genetic laboratory report identifying the familial finding.
  • A relevant family and pregnancy history.
  • Previous genetic counselling or embryo testing reports, if available.

What your care may involve

01

Review of the genetic diagnosis and family history

02

Genetic counselling and laboratory feasibility review

03

Condition-specific test preparation where feasible

04

IVF, embryo biopsy and genetic analysis

05

Results counselling, transfer decisions and pregnancy testing options

What makes PGT-M condition-specific?

PGT-M investigates a particular single-gene condition in embryos created through IVF. The starting point is a defined genetic diagnosis, not a general request to check an embryo for every possible disease. The gene, variant, inheritance pattern and available family information determine whether a test can be prepared.

This differs from PGT-A, which screens chromosome number, and PGT-SR, which addresses structural chromosome rearrangements. One type of test should not be assumed to include the others. The proposed laboratory scope needs to identify the actual question being investigated.

Why preparation can be needed before IVF

A genetics review examines the original diagnostic report and family history. The testing laboratory may need DNA samples from the prospective parents or other relatives to establish how the relevant variant is inherited and to prepare the analysis. Not every family situation or variant can be handled in the same way.

Laboratory feasibility and test preparation can affect timing. Establishing the diagnosis and preparing a suitable assay before embryo creation can avoid a situation in which embryos exist but the intended test has not been defined. The required reports and samples are specific to the laboratory and family.

How inheritance affects the discussion

Examples of why genetic counselling changes the testing plan
SituationWhy it matters
A recessive conditionResults may distinguish embryos affected by the condition from carriers, depending on the inheritance and test design.
A dominant conditionThe relevant variant and its possible effects require condition-specific interpretation.
An X-linked conditionThe inheritance pattern and the proposed test need explanation for that family.
A structural chromosome findingPGT-SR may be the relevant pathway rather than assuming that PGT-M covers it.

Scroll the table sideways to see all columns.

From biopsy to a transfer decision

After IVF and embryo development, suitable embryos may be biopsied and preserved while genetic analysis is performed. The report should state the test used, the result for the condition being investigated and any limitations or inconclusive findings.

The findings then inform embryo-transfer discussions together with embryo development and the clinical context. For some recessive conditions, an embryo may carry a variant without being affected in the same way; carrier findings need the appropriate explanation rather than being treated as one universal category.

The limits of a targeted test

Testing for one condition does not exclude every genetic, chromosome or health condition. There may also be no embryo suitable for the intended transfer, or a result may be inconclusive. Those possibilities belong in the original decision about the testing pathway.

PGT-M does not remove the need to discuss prenatal screening or diagnostic options after pregnancy. Preserve the genetic report so that the obstetric and genetics teams can understand the condition, method and remaining limitations.

Things to discuss with your doctor

  • A known familial genetic finding and supporting reports may be required. Test preparation can add time before an IVF cycle.
  • The laboratory must confirm feasibility, possible inconclusive results and which conditions the test can assess.
  • PGT-M does not exclude every genetic condition. Discuss prenatal testing and residual risk with your clinicians.

Alternatives and individual decisions

Genetic counselling can explore reproductive options and prenatal diagnostic choices relevant to the condition. The laboratory must establish whether a condition-specific test is feasible.

Can PGT-M be added after a cycle has already started?

Contact the team as early as possible. Condition-specific laboratory preparation may be needed before treatment, and availability cannot be assumed for every diagnosis.

Questions about DLI or PGT-P? Read the terminology guide.

Discuss this treatmentAll treatments